ReP USP - Resultado da busca

Artigo de periodico
microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma (2020)
Roberto, Gabriela Molinari; Lira, Régia Caroline ; Delsin, Lara Elis Alberici; Vieira, Gabriela Maciel ; Silva, Marcela de Oliveira; Hakime, Rodrigo Guedes; Yamashita, Mauricio Eiji de Almeida Santos; Engel, Edgard Eduard ; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Annichini, María Sol Brassesco
Source: Pathology & Oncology Research. Unidades: SVOI, FMRP, FFCLRP
Subjects: OSTEOSSARCOMA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROBERTO, Gabriela Molinari et al. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma. Pathology & Oncology Research, v. 26, n. 2, p. 877-883, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12253-019-00633-0. Acesso em: 17 nov. 2024.
APA
Roberto, G. M., Lira, R. C., Delsin, L. E. A., Vieira, G. M., Silva, M. de O., Hakime, R. G., et al. (2020). microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma. Pathology & Oncology Research, 26( 2), 877-883. doi:10.1007/s12253-019-00633-0
NLM
Roberto GM, Lira RC, Delsin LEA, Vieira GM, Silva M de O, Hakime RG, Yamashita ME de AS, Engel EE, Scrideli CA, Tone LG, Annichini MSB. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma [Internet]. Pathology & Oncology Research. 2020 ; 26( 2): 877-883.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s12253-019-00633-0
Vancouver
Roberto GM, Lira RC, Delsin LEA, Vieira GM, Silva M de O, Hakime RG, Yamashita ME de AS, Engel EE, Scrideli CA, Tone LG, Annichini MSB. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma [Internet]. Pathology & Oncology Research. 2020 ; 26( 2): 877-883.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s12253-019-00633-0
Artigo de periodico
Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups (2018)
Salomão, Karina Bezerra; Cruzeiro, Gustavo Alencastro Veiga; Silva, Ricardo Bonfim; Geron, Lenisa; Ramalho, Fernando Silva; Saggioro, Fabiano Pinto; Neder, Luciano; Moreno, Daniel Antunes; Queiroz, Rosane Gomes de Paula; Aguiar, Simone dos Santos; Cardinalli, Izilda; Yunes, José Andres; Brandalise, Silvia Regina; Brassesco, Maria Sol; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Journal of Neuro-Oncology. Unidades: FMRP, SVOI, FFCLRP
Subjects: MEDULOBLASTOMA, GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALOMÃO, Karina Bezerra et al. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. Journal of Neuro-Oncology, v. 139, n. 1, p. 33-42, 2018Tradução . . Disponível em: https://doi.org/10.1007/s11060-018-2845-1. Acesso em: 17 nov. 2024.
APA
Salomão, K. B., Cruzeiro, G. A. V., Silva, R. B., Geron, L., Ramalho, F. S., Saggioro, F. P., et al. (2018). Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. Journal of Neuro-Oncology, 139( 1), 33-42. doi:10.1007/s11060-018-2845-1
NLM
Salomão KB, Cruzeiro GAV, Silva RB, Geron L, Ramalho FS, Saggioro FP, Neder L, Moreno DA, Queiroz RG de P, Aguiar S dos S, Cardinalli I, Yunes JA, Brandalise SR, Brassesco MS, Scrideli CA, Tone LG. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups [Internet]. Journal of Neuro-Oncology. 2018 ; 139( 1): 33-42.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s11060-018-2845-1
Vancouver
Salomão KB, Cruzeiro GAV, Silva RB, Geron L, Ramalho FS, Saggioro FP, Neder L, Moreno DA, Queiroz RG de P, Aguiar S dos S, Cardinalli I, Yunes JA, Brandalise SR, Brassesco MS, Scrideli CA, Tone LG. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups [Internet]. Journal of Neuro-Oncology. 2018 ; 139( 1): 33-42.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s11060-018-2845-1
Artigo de periodico
Intracranial teratoma in children: the role of chromosome 21 trisomy (2014)
Ferraz, Sabrine Teixeira; Valera, Elvis Terci; Brassesco, María Sol; Oliveira, Ricardo Santos de; Santos, Antônio Carlos dos; Saggioro, Fabiano Pinto; Neder, Luciano; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Neuropathology. Unidades: FMRP, FFCLRP, SVOI
Subjects: SISTEMA NERVOSO CENTRAL, SÍNDROME DE DOWN, TERATOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAZ, Sabrine Teixeira et al. Intracranial teratoma in children: the role of chromosome 21 trisomy. Neuropathology, v. 34, n. 2, p. 197-200, 2014Tradução . . Disponível em: https://doi.org/10.1111/neup.12077. Acesso em: 17 nov. 2024.
APA
Ferraz, S. T., Valera, E. T., Brassesco, M. S., Oliveira, R. S. de, Santos, A. C. dos, Saggioro, F. P., et al. (2014). Intracranial teratoma in children: the role of chromosome 21 trisomy. Neuropathology, 34( 2), 197-200. doi:10.1111/neup.12077
NLM
Ferraz ST, Valera ET, Brassesco MS, Oliveira RS de, Santos AC dos, Saggioro FP, Neder L, Scrideli CA, Tone LG. Intracranial teratoma in children: the role of chromosome 21 trisomy [Internet]. Neuropathology. 2014 ;34( 2): 197-200.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/neup.12077
Vancouver
Ferraz ST, Valera ET, Brassesco MS, Oliveira RS de, Santos AC dos, Saggioro FP, Neder L, Scrideli CA, Tone LG. Intracranial teratoma in children: the role of chromosome 21 trisomy [Internet]. Neuropathology. 2014 ;34( 2): 197-200.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/neup.12077

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Indexado em